HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?

AuthorsAndrea DeCensi, Giancarlo Pruneri, Aliana Guerrieri-Gonzaga
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 30 Issue 12 Pg. 1384-6 (Apr 20 2012) ISSN: 1527-7755 [Electronic] United States
PMID22393083 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers, Tumor
  • Receptors, Estrogen
Topics
  • Biomarkers, Tumor (metabolism)
  • Breast Neoplasms (metabolism, mortality, pathology, therapy)
  • Carcinoma in Situ (metabolism, mortality, pathology, therapy)
  • Carcinoma, Ductal, Breast (metabolism, mortality, pathology, therapy)
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Humans
  • Neoplasm Staging
  • Predictive Value of Tests
  • Receptors, Estrogen (metabolism)
  • Risk Assessment
  • Signal Transduction
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: